logo
Select company
Select metric
-118.59%Free Cash Flow Margin
VS
Market
12
Sector
36
Industry
65
History
47
$ 13.63Close
$ 5.57 - $ 16.36 52-Week Range
Ticker Information

Ticker

DNA

Company Name

GINKGO BIOWORKS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

GINKGO BIOWORKS HOLDINGS INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DNA - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -273.71M-118.59%$ 230.81M
3/31/2025$ -344.65M-145.17%$ 237.42M
12/31/2024$ -381.48M-168.02%$ 227.04M
9/30/2024$ -385.24M-176.75%$ 217.95M
6/30/2024$ -344.91M-187.11%$ 184.34M
3/31/2024$ -318.43M-152.58%$ 208.7M
12/31/2023$ -331.87M-131.98%$ 251.46M
9/30/2023$ -402.37M-127.74%$ 314.99M
6/30/2023$ -366.29M-112.37%$ 325.95M
3/31/2023$ -390.4M-100.1%$ 390M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GINKGO BIOWORKS HOLDINGS INC's latest trailing twelve months (TTM) FCF % stands at -84.48%.
  • Over the past 5 years, GINKGO BIOWORKS HOLDINGS INC's average FCF % has been -115.7%.
  • The median FCF % for GINKGO BIOWORKS HOLDINGS INC during this period was -115.48%
  • GINKGO BIOWORKS HOLDINGS INC reached its highest FCF % over the past 5 years at -58.18%.
  • The lowest FCF % recorded by GINKGO BIOWORKS HOLDINGS INC in the same timeframe -187.11%

GINKGO BIOWORKS HOLDINGS INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
AKBA : AKEBIA THERAPEUTICS INC -1.17%STOK : STOKE THERAPEUTICS INC 30.59%IOVA : IOVANCE BIOTHERAPEUTICS INC -133.96%KROS : KEROS THERAPEUTICS INC 22.8%DAWN : DAY ONE BIOPHARMACEUTICALS INC -34.9%GERN : GERON CORP -108.41%RCUS : ARCUS BIOSCIENCES INC -130.53%XERS : XERIS BIOPHARMA HOLDINGS INC -6.82%MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -18.82%CRMD : CORMEDIX INC 25.03%

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for GINKGO BIOWORKS HOLDINGS INC is calculated as follows: FCF [ $ -139.68M ] / Revenues [ $ 165.34M ]
(=) FCF % [ -84.48% ]

DNA - Free Cash Flow Margin, Last 5 years

-187.11%

Minimum

Jun 30, 2024

-58.18%

Maximum

Jun 30, 2022

-115.7%

Average

-115.48%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.86% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.86%
median7.37%
std19.48%